Carroll, Camille

Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson’s disease

Hilton, D., Stephens, M., Kirk, L., Edwards, P., Potter, R., Zajicek, J., Broughton, E., Hagan, H., & Carroll, C. (2014) · Acta Neuropathologica

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 345

Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process

Witham, M. D., Anderson, E., Carroll, C., Dark, P. M., Down, K., Hall, A. S., Knee, J., Maier, R. H., Mountain, G. A., Nestor, G., et al. (2020) · Trials

Ethics in Clinical ResearchMental Health and Patient Involvement

Cited by 259

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial

Vijiaratnam, N., Girges, C., Auld, G., McComish, R., King, A., Skene, S. S., Hibbert, S., Wong, A., Melander, S., Gibson, R., et al. (2025) · The Lancet

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 181

Research with older people in a world with COVID-19: identification of current and future priorities, challenges and opportunities

Richardson, S. J., Carroll, C. B., Close, J., Gordon, A. L., O’Brien, J., Quinn, T. J., Rochester, L., Sayer, A. A., Shenkin, S. D., van der Velde, N., et al. (2020) · Age and Ageing

Geriatric Care and Nursing HomesTechnology Use by Older Adults

Cited by 128

Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson’s disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The ‘Exenatide-PD3’ study

Vijiaratnam, N., Girges, C., Auld, G., Chau, M., Maclagan, K., King, A., Skene, S., Chowdhury, K., Hibbert, S., Morris, H., et al. (2021) · BMJ Open

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 84

A Qualitative Study on the Impact of First Steps—A Peer-led Educational Intervention for People Newly Diagnosed with Parkinson’s Disease

Soundy, A., Collett, J., Lawrie, S., Coe, S., Roberts, H., Hu, M., Bromley, S., Harling, P., Reed, A., Coeberg, J., et al. (2019) · Behavioral Sciences

Parkinson's Disease Mechanisms and TreatmentsCancer survivorship and care

Cited by 22

Accelerating Parkinson’s Disease drug development with federated learning approaches

Khanna, A., Adams, J., Antoniades, C., Bloem, B. R., Carroll, C., Cedarbaum, J., Cosman, J., Dexter, D. T., Dockendorf, M. F., Edgerton, J., et al. (2024) · npj Parkinson's Disease

Privacy-Preserving Technologies in DataParkinson's Disease Mechanisms and Treatments

Cited by 21

Artificial Intelligence Applications for Assessment, Monitoring, and Management of Parkinson Disease Symptoms: Protocol for a Systematic Review

Bounsall, K., Milne-Ives, M., Hall, A., Carroll, C., & Meinert, E. (2023) · JMIR Research Protocols

Parkinson's Disease Mechanisms and TreatmentsArtificial Intelligence in Healthcare

Cited by 16